Daré Bioscience Reports Q3 Net Loss of $3.2M, Down From $3.6M
Q3 2026 net loss was approximately $3.2M, compared with approximately $3.6M a year earlier; revenue was approximately $48K versus approximately $2.3K. The company had approximately $11.5M in cash and cash equivalents at September 30, 2026.Material DetailsContext by AI AnalystThis is an early commer…